MICHAEL E ALTMAN
Broker in Needham, MA
License number
Massachusetts 9076711
Issued Date
May 12, 2005
Expiration Date
Aug 25, 2017
Type
Broker
Address
Address
Needham, MA 02494
Personal information
See more information about MICHAEL E ALTMAN at radaris.comName
Address
Phone
540 Huron Ave, Cambridge, MA 02138
4 Coolidge St, Auburn, MA 01501
PO Box 94, Yarmouth Port, MA 02675
18 Maple St, Watertown, MA 02472
Professional information
See more information about MICHAEL E ALTMAN at trustoria.com
Michael Altman - Needham, MA
Michael Altman - Needham, MA
Work:
CBRE, Global Corporate Services - Sovereign Bank for the New England Area
Senior Transaction Manager ATS Real Estate - Waltham, MA
Principal The Triad Group - Boston, MA
Commercial Real Estate Salesman
Senior Transaction Manager ATS Real Estate - Waltham, MA
Principal The Triad Group - Boston, MA
Commercial Real Estate Salesman
Education:
1. University of Vermont
Bachelor of Science in Small Business Administration
Bachelor of Science in Small Business Administration
Skills:
Strong analytical, quantitative, and problem solving skills The ability to work independently as well as in a team environment Experience in sourcing, manipulating and presenting data Accustomed to environments where deadlines are a priority and handling simultaneous assignments is required Skilled Leadership/Team Building Transactions Management Strong Microsoft Excel skills and an aptitude for technology Deal Maker High energy, but good listener Client Satisfaction
Pyrazolo[1,5-A]Pyrimidines As Mark Inhibitors
Pyrazolo[1,5-A]Pyrimidines As Mark Inhibitors
US Patent:
2013021, Aug 15, 2013
Filed:
Jan 11, 2011
Appl. No.:
13/521382
Inventors:
Jongwon Lim - Lexington MA, US
Brandon M. Taoka - Hoboken NJ, US
Sandra Lee - Princeton NJ, US
Alan Northrup - Reading MA, US
Michael D. Altman - Needham MA, US
David L. Sloman - Boston MA, US
Matthew G. Stanton - Marlton NJ, US
Brandon M. Taoka - Hoboken NJ, US
Sandra Lee - Princeton NJ, US
Alan Northrup - Reading MA, US
Michael D. Altman - Needham MA, US
David L. Sloman - Boston MA, US
Matthew G. Stanton - Marlton NJ, US
International Classification:
C07D 487/04
US Classification:
5142593, 544281
Abstract:
The invention encompasses pyrazolo[1,5-a]pyrimidine derivatives which selectively inhibit microtubule affinity regulating kinase (MARK) and are therefore useful for the treatment or prevention of Alzheimer's disease. Pharmaceutical compositions and methods of use are also included.
Inhibitors Of Janus Kinases
Inhibitors Of Janus Kinases
US Patent:
8415346, Apr 9, 2013
Filed:
Jul 21, 2009
Appl. No.:
13/056180
Inventors:
Michael Altman - Needham MA, US
Kevin Wilson - West Newton MA, US
Kevin Wilson - West Newton MA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/541, A61K 31/5377, A61K 31/496, C07D 231/38, C07D 413/12, C07D 403/12, C07D 417/12
US Classification:
5142278, 5142365, 51425405, 514407, 544 582, 544140, 544371, 5483717
Abstract:
The instant invention provides for compounds that inhibit the four known mammalian JAK kinases (JAK1, JAK2, JAK3 and TYK2). The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting the activity of JAK1, JAK2, JAK3 and TYK2 by administering the compound to a patient in need of treatment for myeloproliferative disorders or cancer.
Imidazo[1,2-A]Pyridines And Imidazo[1,2-B]Pyridazines As Mark Inhibitors
Imidazo[1,2-A]Pyridines And Imidazo[1,2-B]Pyridazines As Mark Inhibitors
US Patent:
8592425, Nov 26, 2013
Filed:
Jan 12, 2010
Appl. No.:
13/144123
Inventors:
Michael D. Altman - Needham MA, US
Mark T. Bilodeau - Lansdale PA, US
Jongwon Lim - Lexington MA, US
Alan Northrup - Reading MA, US
Matthew G. Stanton - Holland PA, US
Brandon M. Taoka - Allston MA, US
Mark T. Bilodeau - Lansdale PA, US
Jongwon Lim - Lexington MA, US
Alan Northrup - Reading MA, US
Matthew G. Stanton - Holland PA, US
Brandon M. Taoka - Allston MA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A01N 43/58, A61K 31/50, C07D 487/00
US Classification:
514250, 544236
Abstract:
The invention encompasses imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives which selectively inhibit microtubule affinity regulating kinase (MARK) and are therefore useful for the treatment or prevention of Alzheimer's disease. Pharmaceutical compositions and methods of use are also included.
Inhibitors Of Janus Kinases
Inhibitors Of Janus Kinases
US Patent:
8278335, Oct 2, 2012
Filed:
Apr 9, 2009
Appl. No.:
12/988705
Inventors:
Michelle R. Machacek - Brookline MA, US
Andrew Haidle - Cambridge MA, US
Anna A. Zabierek - Boston MA, US
Kaleen M. Konrad - Boston MA, US
Michael D. Altman - Needham MA, US
Andrew Haidle - Cambridge MA, US
Anna A. Zabierek - Boston MA, US
Kaleen M. Konrad - Boston MA, US
Michael D. Altman - Needham MA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A01N 43/40, A61K 31/44
US Classification:
514342, 51425205, 5462697, 544238
Abstract:
The instant invention provides for compounds that inhibit the four known mammalian JAK kinases (JAK1, JAK2, JAK3 and TYK2) and PDK1. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting the activity of JAK1, JAK2, JAK3, TYK2 and PDK1 by administering the compound to a patient in need of treatment for myeloproliferative disorders or cancer.
Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
US Patent:
2012026, Oct 18, 2012
Filed:
Dec 14, 2010
Appl. No.:
13/517321
Inventors:
Jonathan Young - Southborough MA, US
Barbara Czako - Houston TX, US
Michael Altman - Needham MA, US
David Guerin - Natick MA, US
Michelle Martinez - Medford MA, US
Alexey Rivkin - Emeryville CA, US
Kevin Wilson - Newton MA, US
Kathryn Lipford - Boston MA, US
Catherine White - Newton Center MA, US
Laura Surdi - Franklin MA, US
Stephanie Chichetti - Bay Shore NY, US
Matthew H. Daniels - Cambridge MA, US
Sean P. Ahearn - Somerville MA, US
Danielle Falcone - Brookline MA, US
Ekundayo Osimboni - Ashland MA, US
Barbara Czako - Houston TX, US
Michael Altman - Needham MA, US
David Guerin - Natick MA, US
Michelle Martinez - Medford MA, US
Alexey Rivkin - Emeryville CA, US
Kevin Wilson - Newton MA, US
Kathryn Lipford - Boston MA, US
Catherine White - Newton Center MA, US
Laura Surdi - Franklin MA, US
Stephanie Chichetti - Bay Shore NY, US
Matthew H. Daniels - Cambridge MA, US
Sean P. Ahearn - Somerville MA, US
Danielle Falcone - Brookline MA, US
Ekundayo Osimboni - Ashland MA, US
International Classification:
A61K 31/501, A61K 31/506, C07D 413/12, A61P 35/00, C07D 413/14, C07D 417/14, A61K 31/541, C07D 403/04, A61K 31/5377
US Classification:
51421018, 544238, 51425205, 51425202, 544114, 5142365, 544122, 544 586, 5142278, 544 582
Abstract:
The present invention relates to pyridazin-4(1H)-one derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
Aminopyrimidines As Syk Inhibitors
Aminopyrimidines As Syk Inhibitors
US Patent:
2012030, Dec 6, 2012
Filed:
Dec 16, 2010
Appl. No.:
13/515941
Inventors:
Michael D. Altman - Needham MA, US
Kenneth L. Arrington - Revere MA, US
Jason Burch - Redwood City CA, US
Bernard Cote - Notre-Dame-de-I'lle-Perrot, CA
Jean-Francois Fournier - Juan les Pins, FR
Jacques Yves Gauthier - Laval des Rapides, CA
Solomon Kattar - Arlington MA, US
Sandra Lee Knowles - Princeton NJ, US
Jongwon Lim - Lexington MA, US
Michelle R. Machacek - Brookline MA, US
Alan B. Northrup - Reading MA, US
Michael H. Reutershan - Brookline MA, US
Joel S. Robichaud - Dollard des Ormeaux, CA
Adam J. Schell - Decatur GA, US
Kerrie B. Spencer - Woonsocket RI, US
Kenneth L. Arrington - Revere MA, US
Jason Burch - Redwood City CA, US
Bernard Cote - Notre-Dame-de-I'lle-Perrot, CA
Jean-Francois Fournier - Juan les Pins, FR
Jacques Yves Gauthier - Laval des Rapides, CA
Solomon Kattar - Arlington MA, US
Sandra Lee Knowles - Princeton NJ, US
Jongwon Lim - Lexington MA, US
Michelle R. Machacek - Brookline MA, US
Alan B. Northrup - Reading MA, US
Michael H. Reutershan - Brookline MA, US
Joel S. Robichaud - Dollard des Ormeaux, CA
Adam J. Schell - Decatur GA, US
Kerrie B. Spencer - Woonsocket RI, US
International Classification:
A61K 31/506, C07D 417/12, C07D 417/14, C07D 471/04, A61P 19/02, A61K 31/551, A61P 11/06, A61P 11/00, A61P 29/00, C07D 471/10, A61K 31/5377
US Classification:
5142102, 544230, 514275, 544331, 544296, 544295, 51425505, 544122, 5142358, 51425219, 540492, 514218, 514249, 540575
Abstract:
The present invention provides novel pyrimidine amines of formula (I) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis.
Aminopyrimidines As Syk Inhibitors
Aminopyrimidines As Syk Inhibitors
US Patent:
2012027, Nov 1, 2012
Filed:
Dec 15, 2010
Appl. No.:
13/516455
Inventors:
Michael D. Altman - Needham MA, US
Brian M. Andresen - Sharon MA, US
Kenneth L. Arrington - Revere MA, US
Sathesh Bhat - Dollard-des-Ormeaux, CA
Jason Burch - Redwood City CA, US
Kaleen Konrad Childers - Newton MA, US
Bernard Cote - Notre-Dame-de-I'Ile-Perrot, CA
Maria Emilia Di Francesco - Houston TX, US
Anthony Donofrio - Cambridge MA, US
Kristina Dupont-Gaudet - Vaudreuil-Dorion, CA
John Michael Ellis - Needham MA, US
Christian Fischer - Natick MA, US
Jean-Francois Fournier - Montreal, CA
Jacques Yves Gauthier - Laval, CA
Jonathan Grimm - Asburn VA, US
Daniel Guay - Lachine, CA
David Joseph Guerin - Natick MA, US
Andrew M. Haidle - Cambridge MA, US
Solomon Kattar - Arlington MA, US
Sandra Lee Knowles - Princeton NJ, US
Chaomin Li - Boston MA, US
Jongwon Lim - Lexintong MA, US
Michelle R. Machacek - Brookline MA, US
Matthew L. Maddess - Boston MA, US
Alan B. Northrup - Reading MA, US
Brendan M. O'Boyle - Boston MA, US
Ryan D. Otte - Natick MA, US
Alessia Petrocchi - Houston TX, US
Michael H. Reutershan - Brookline MA, US
Joel S. Robichaud - Dollar-des-Ormeaux, CA
Eric Romeo - Allston MA, US
Adam J. Schell - Decatur GA, US
Tony Siu - Brookline MA, US
Kerrie B. Spencer - Woonsocket RI, US
Brandon M. Taoka - Hoboken NJ, US
B. Wesley Trotter - Newton Highlands MA, US
Hyun Chong Woo - Natick MA, US
Hua Zhou - Acton MA, US
Brian M. Andresen - Sharon MA, US
Kenneth L. Arrington - Revere MA, US
Sathesh Bhat - Dollard-des-Ormeaux, CA
Jason Burch - Redwood City CA, US
Kaleen Konrad Childers - Newton MA, US
Bernard Cote - Notre-Dame-de-I'Ile-Perrot, CA
Maria Emilia Di Francesco - Houston TX, US
Anthony Donofrio - Cambridge MA, US
Kristina Dupont-Gaudet - Vaudreuil-Dorion, CA
John Michael Ellis - Needham MA, US
Christian Fischer - Natick MA, US
Jean-Francois Fournier - Montreal, CA
Jacques Yves Gauthier - Laval, CA
Jonathan Grimm - Asburn VA, US
Daniel Guay - Lachine, CA
David Joseph Guerin - Natick MA, US
Andrew M. Haidle - Cambridge MA, US
Solomon Kattar - Arlington MA, US
Sandra Lee Knowles - Princeton NJ, US
Chaomin Li - Boston MA, US
Jongwon Lim - Lexintong MA, US
Michelle R. Machacek - Brookline MA, US
Matthew L. Maddess - Boston MA, US
Alan B. Northrup - Reading MA, US
Brendan M. O'Boyle - Boston MA, US
Ryan D. Otte - Natick MA, US
Alessia Petrocchi - Houston TX, US
Michael H. Reutershan - Brookline MA, US
Joel S. Robichaud - Dollar-des-Ormeaux, CA
Eric Romeo - Allston MA, US
Adam J. Schell - Decatur GA, US
Tony Siu - Brookline MA, US
Kerrie B. Spencer - Woonsocket RI, US
Brandon M. Taoka - Hoboken NJ, US
B. Wesley Trotter - Newton Highlands MA, US
Hyun Chong Woo - Natick MA, US
Hua Zhou - Acton MA, US
International Classification:
A61K 31/506, A61K 31/55, A61K 31/554, A61K 31/551, A61P 35/00, C07D 417/14, C07F 9/6539, C07D 417/12, A61P 19/02, A61P 11/06, A61K 31/675, A61K 31/5377
US Classification:
514 86, 5142102, 51421202, 51421208, 514218, 5142358, 514249, 514275, 540488, 540492, 540524, 544123, 544243, 544321
Abstract:
The present invention provides novel pyrimidine amines of formula (I) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis.
Tyrosine Kinase Inhibitors
Tyrosine Kinase Inhibitors
US Patent:
2013011, May 9, 2013
Filed:
Jul 7, 2011
Appl. No.:
13/809436
Inventors:
Kevin Wilson - Newton MA, US
Michael Altman - Needham MA, US
Kathryn Lipford - Boston MA, US
Catherine White - Newton Center MA, US
Matthew Daniels - Cambridge MA, US
Michael Altman - Needham MA, US
Kathryn Lipford - Boston MA, US
Catherine White - Newton Center MA, US
Matthew Daniels - Cambridge MA, US
International Classification:
C07D 411/14, C07D 403/14, C07D 403/04, C07D 401/14, C07D 401/12
US Classification:
51421018, 544238, 51425204, 51425205, 51425202, 544114, 5142352
Abstract:
The present invention relates to 1,4-dihydropyridazinone derivatives, that are useful for treating cellular proliferative diseases, for treating disorders associated with MET activity, and for inhibiting the receptor tyrosine kinase MET. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
Aminopyrimidines As Syk Inhibitors
Aminopyrimidines As Syk Inhibitors
US Patent:
8551984, Oct 8, 2013
Filed:
Dec 15, 2010
Appl. No.:
12/968608
Inventors:
Michael D. Altman - Needham MA, US
Brian M. Andresen - Sharon MA, US
Kenneth L. Arrington - Revere MA, US
Jason Burch - Westmount, CA
Kaleen Konrad Childers - Newton MA, US
Bernard Cote - Notre-Dame-de-l'lle-Perrot, CA
Maria Emilia Di Francesco - Brookline MA, US
Anthony Donofrio - Cambridge MA, US
Kristina Dupont-Gaudet - Vaudreuil-Dorion, CA
John Michael Ellis - Needham MA, US
Christian Fischer - Natick MA, US
Daniel Guay - Lachine, CA
David Joseph Guerin - Natick MA, US
Andrew M. Haidle - Cambridge MA, US
Solomon Kattar - Arlington MA, US
Sandra Lee Knowles - Boston MA, US
Chaomin Li - Boston MA, US
Jongwon Lim - Lexington MA, US
Michelle R. Machacek - Brookline MA, US
Alan B. Northrup - Reading MA, US
Brendan M. O'Boyle - Boston MA, US
Ryan D. Otte - Natick MA, US
Michael H. Reutershan - Brookline MA, US
Eric Romeo - Alliston MA, US
Adam J. Schell - Newton MA, US
Tony Siu - Brookline MA, US
Kerrie B. Spencer - Woonsocket RI, US
Brandon M. Taoka - Brookline MA, US
B. Wesley Trotter - Newton Highland MA, US
Hua Zhou - Acton MA, US
Brian M. Andresen - Sharon MA, US
Kenneth L. Arrington - Revere MA, US
Jason Burch - Westmount, CA
Kaleen Konrad Childers - Newton MA, US
Bernard Cote - Notre-Dame-de-l'lle-Perrot, CA
Maria Emilia Di Francesco - Brookline MA, US
Anthony Donofrio - Cambridge MA, US
Kristina Dupont-Gaudet - Vaudreuil-Dorion, CA
John Michael Ellis - Needham MA, US
Christian Fischer - Natick MA, US
Daniel Guay - Lachine, CA
David Joseph Guerin - Natick MA, US
Andrew M. Haidle - Cambridge MA, US
Solomon Kattar - Arlington MA, US
Sandra Lee Knowles - Boston MA, US
Chaomin Li - Boston MA, US
Jongwon Lim - Lexington MA, US
Michelle R. Machacek - Brookline MA, US
Alan B. Northrup - Reading MA, US
Brendan M. O'Boyle - Boston MA, US
Ryan D. Otte - Natick MA, US
Michael H. Reutershan - Brookline MA, US
Eric Romeo - Alliston MA, US
Adam J. Schell - Newton MA, US
Tony Siu - Brookline MA, US
Kerrie B. Spencer - Woonsocket RI, US
Brandon M. Taoka - Brookline MA, US
B. Wesley Trotter - Newton Highland MA, US
Hua Zhou - Acton MA, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
Merck Canada Inc. - Kirkland, Quebec
Merck Canada Inc. - Kirkland, Quebec
International Classification:
C07D 417/12, A61K 31/497
US Classification:
51421208, 51421706, 5142358, 51425202, 51425219, 514275, 540524, 540601, 544122, 544238, 544295, 544296, 544331
Abstract:
The present invention provides novel pyrimidine amines of formula (I) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis.